Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

News Daily News

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Yael L. Maxwell

September 14, 2016

News Daily News

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Yael L. Maxwell

September 14, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Daily News

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Yael L. Maxwell

June 15, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

November 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Daily News

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

September 09, 2015

News Daily News

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

September 09, 2015

Advertisement

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

What TAVR Needs Next . . . and What It’s Getting

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

Low 1-Year Event Rates Seen After TAVR With Sapien 3

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Updates to CoreValve Extreme Risk Study Encouraging

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content